Advertisement
Advertisement
January 27, 2025
Gore Excluder Conformable AAA Endoprosthesis With Active Control Approved and Launched in Canada
January 27, 2025—Gore & Associates recently announced the first commercial use of the company’s Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis with Active Control system in Canada.
The announcement coincides with Health Canada approval of the device for the treatment of AAA patients with aortic landing zones as short as 10 mm and neck angulation up to 90°, noted the company.
Kevin Lee, MD, used the device commercially for the first time.
“With the conformability of its nested stent design, angulation control, and two-stage deployment, the Gore Excluder conformable AAA device gives us the only option for endovascular repair of difficult angulated anatomy,” commented Dr. Lee in the company’s press release. “We can reconstrain. We can reposition. And we can refine angulation. That means more control, more precision, and more opportunities to achieve optimal seal.”
Dr. Lee continued, “Today was a major milestone for the tools and techniques at our disposal, and it built on the performance we’ve come to rely on over the years using the Gore Excluder device family. That really is a rare recipe for confidence with a new device.”
Advertisement
Advertisement
